Clinical Trials Directory

Trials / Unknown

UnknownNCT05189964

Total Hip Arthroplasty and Physical Activity in Patients Younger Than 50 Years

Status
Unknown
Phase
Study type
Observational
Enrollment
90 (estimated)
Sponsor
Radboud University Medical Center · Academic / Other
Sex
All
Age
16 Years – 50 Years
Healthy volunteers

Summary

Rationale: THA is a widely applied procedure for osteoarthritis of the hip. After THA, one can expect an increase in physical activity due to the reduction of pain and increased range of motion of the hip joint, especially in young patients who in general have more active lifestyles. However, these young patients and their doctors don't know which increase in physical activity can be expected. Objective: To measure the difference in physical activity before and after THA. Study design: Longitudinal prospective single center observational study. Study population: 87 patients who have primary THA under the age of 50 years. Excluding patients with an underlying oncologic disease which results in THA. Intervention: N.a. Main study parameters/endpoints: The first primary endpoint is physical activity in minutes per day. The other primary endpoint is MVPA in minutes per day. Secondary endpoints are difference of TUG outcomes in seconds and the difference of 6MWT outcomes in meters. For the patients experience, the COPM total scores and NRS pain scores will be measured. Nature and extent of the burden and risks associated with participation, benefit and group relatedness: This study requires three outpatient clinic visits. These visits will coincide with regular outpatient clinic visits, so patients will not have to come in extra for this study. During the preoperative and 1 year postoperative visit, the patients will complete the COPM. The patient will wear a PA monitor for 7 days after each visit. Patients might experience confronting feelings while being exposed to their PA activity profile after the study or experience mild discomfort while wearing the PA monitor since it will be worn 24 hours per day for 7 days. Also, filling in the questionnaires will take some time (5-10 minutes per questionnaire series). There are no significant physical risks associated to this study.

Conditions

Timeline

Start date
2021-12-01
Primary completion
2023-12-01
Completion
2024-10-01
First posted
2022-01-13
Last updated
2022-01-13

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT05189964. Inclusion in this directory is not an endorsement.